Biotechnology in Japan

Biotechnology in Japan


August 27, 2013
35 Pages - SKU: MTLN5108820
License type:
Online Download      US $350.00
Site License      US $665.00
Global Site License      US $875.00
Countries covered: Japan

Biotechnology in Japan

Introduction

Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Japan biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights
  • The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
  • The Japanese biotechnology market had total revenues of $43.3bn in 2012, representing a compound annual growth rate (CAGR) of 3.8% between 2008 and 2012.
  • The competitiveness of the Japanese biotechnology industry is underpinned by the country’s high share of biotechnology patents filed under primary care trust and the high amount of biotechnology R&D expenditures in the business sector.
  • The performance of the market is forecast to accelerate, with an anticipated CAGR of 4.4% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $53.8bn by the end of 2017.
Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Japan

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Japan

Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Japan biotechnology market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Japan economy

Key Questions Answered

What was the size of the Japan biotechnology market by value in 2012?

What will be the size of the Japan biotechnology market in 2017?

What factors are affecting the strength of competition in the Japan biotechnology market?

How has the market performed over the last five years?

What are the main segments that make up Japan's biotechnology market?



More Research & Development reports by MarketLine

Biotechnology in the United States by MarketLine
Biotechnology in the United StatesIntroductionBiotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast ...
Biotechnology in the United Kingdom by MarketLine
Biotechnology in the United KingdomIntroductionBiotechnology in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast ...
Biotechnology in the Netherlands by MarketLine
Biotechnology in the NetherlandsIntroductionBiotechnology in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). ...
Biotechnology in Spain by MarketLine
Biotechnology in SpainIntroductionBiotechnology in Spain industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). The profile ...
See all reports like this >>

More Japan Research & Development reports

Biotechnology in Japan by MarketLine
Datamonitor's Biotechnology in Japan industry profile is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes data on market size ...
The 2009-2014 Outlook for Regenerative Medicine in Japan by Icon Group International, Inc.
This econometric study covers the latent demand outlook for regenerative medicine across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), ...
See all reports like this >>

More Japan reports

D&B Country Report: Japan by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>